hero Hcp hero Hcp real Hcp
hero text

Help Curb Hard Belly*

Introducing NEW EGRIFTA SV™: A once-daily subcutaneous injection with a small volume of administration
  • Concentrated strength, dosed in a single vial
  • Injection volume of only 0.35 mL
  • Small needle size (½” 30-gauge needle)
  • Store at room temperature (no refrigeration required)
A newly FDA approved treatment indicated for the treatment of Hard Belly in HIV-infected adult patients with lipodystrophy

Proven to significantly reduce excess abdominal fat.

See the Results
How does EGRIFTA SV™ work?

It stimulates the body's own pulsatile release of growth hormone.

Learn about the mechanism of action
Get your patients started and staying on therapy

THERA patient support® offers comprehensive services and personal support for you and your patients.

Find out more

*Also known as excess abdominal fat.

†A newly approved strength of tesamorelin for injection with the same efficacy and safety of tesamorelin 1 mg/vial. The 2 mg/vial is more concentrated than the 1 mg/vial, and the recommended daily dose is 1.4 mg.